HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

JIANGXI BIO

16.000

+0.7204.71%

Volume:2.83M

Turnover:44.56M

Market Cap:4.93B

PE:39.36

High:16.820

Open:15.000

Low:14.310

Close:15.280

52wk High:17.460

52wk Low:3.950

Shares:308.38M

HK Float Shares:307.00M

Volume Ratio:1.95

T/O Rate:0.92%

Dividend:- -

Dividend Rate:- -

EPS(LYR):0.406

ROE:21.04%

ROA:12.08%

PB:8.49

PE(LYR):39.36

PS:17.96

Loading ...

Overview Company News Filings

CMSC Initiates Coverage on JIANGXI BIO with "Accumulate" Rating and HK$23.6 Target Price

China Merchants Securities Starts Jiangxi Institute of Biological Products at Buy with HK$23.60 Price Target

MT Newswires Live

Jiangxi Institute of Biological Products Schedules Board Meeting to Release Interim Results

Jiangxi Bio Executive Director Buys 1.128 Million Shares Over Three Days, Stake Rises to 0.37%

Jiangxi Bio's Stock Surges Nearly 320% in Two Weeks, Reversing Its IPO Slump

Jiangxi Institute of Biological Products - Commences Veterinary Tetanus Antitoxin Production on July 20, 2026

THOMSON REUTERS

Jiangxi Bio Products Unit Chifeng Bo-en Starts Veterinary Tetanus Antitoxin Production Line

Jiangxi Bio (06915) Concludes Price Stabilization Period, Over-Allotment Option Lapses

Jiangxi Bio Ends Stabilization; Over-Allotment Option Lapses with No Additional H-Share Issuance

Bulletin Express

Jiangxi Institute of Biological Products Says Stabilizing Manager Buys 5,435,000 H Shares at Hk$7.4-hk$10.46

HK Movers | Jiangxi Bio Rallied Nearly 40% Intraday

MT Newswires Live

JIANGXI BIO Surges Over 17% to Record High After Subsidiary Obtains Veterinary Tetanus Antitoxin Approval

Jiangxi Institute of Biological Products Says Unit Obtains Approval Certificate for Veterinary Tetanus Antitoxin

Jiangxi Bio: First Post-Listing Monthly Return Shows Stable Share Capital and Full Public Float Compliance

Bulletin Express

Jiangxi Institute of Biological Products Sets Final Offer Price Under Global Offering at Hk$11.2 Per H Share

Jiangxi Institute of Biological Products Sets Final Offer Price Under Global Offering at Hk$11.2 Per H Share

Jiangxi Bio Unit Wins China Nod for Veterinary Tetanus Antitoxin

MT Newswires Live

Movement Alert｜Jiangxi Biologics Rises 9.52% in Regular Trading, Subsidiary Obtains Veterinary Tetanus Antitoxin Product Approval

JIANGXI BIO's Wholly-Owned Subsidiary Secures Regulatory Approval for Veterinary Tetanus Antitoxin

Jiangxi Bio Gains Regulatory Green Light for Veterinary Tetanus Antitoxin, Expanding Animal Health Pipeline

Bulletin Express

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/06915/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"06915","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06915\",,,,,undefined,":{"symbol":"06915","market":"HK","secType":"STK","nameCN":"JIANGXI BIO","latestPrice":16,"timestamp":1787299687121,"preClose":15.28,"halted":0,"volume":2834000,"delay":0,"changeRate":0.04712041884816758,"floatShares":307000000,"shares":308377319,"eps":0.4064549325094684,"marketStatus":"Market Closed","change":0.72,"latestTime":"08-21 16:08:07","open":15,"high":16.82,"low":14.31,"amount":44560685,"amplitude":0.164267,"askPrice":16.5,"askSize":5500,"bidPrice":16,"bidSize":15500,"shortable":0,"etf":0,"ttmEps":0.39674176069756684,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":7,"adr":0,"listingDate":1782748800000,"exchange":"SEHK","adjPreClose":15.28,"openAndCloseTimeList":[[1787275800000,1787284800000],[1787288400000,1787299200000]],"volumeRatio":1.9538093009416446,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06915\",,,,,undefined,":{"symbol":"06915","floatShares":307000000,"roa":"12.08%","roe":"21.04%","lyrEps":0.406455,"volumeRatio":1.9538093009416446,"shares":308377319,"dividePrice":0,"high":16.82,"amplitude":0.164267,"preClose":15.28,"low":14.31,"week52Low":3.95,"pbRate":"8.49","psRate":"17.96","week52High":17.46,"institutionHeld":0,"latestPrice":16,"committee":0.47619,"eps":0.4064549325094684,"divideRate":0,"volume":2834000,"delay":0,"ttmEps":0.39674176069756684,"open":15,"prevYearClose":11.2,"prevWeekClose":14,"prevMonthClose":15.29,"prevQuarterClose":9.78,"fiveDayClose":14,"twentyDayClose":12.81,"sixtyDayClose":11.2,"earningDate":1788105600000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06915\",params:#limit:5,,,undefined,":[{"date":"2026-08-31","symbol":"06915","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1788139800000,"name":null,"time":"","dateTimestamp":1788105600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06915\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06915\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06915\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06915","date":"2026-08-21","current":40.3285,"percent":0.971429,"low":11.368674,"twenty":14.976114,"median":28.865244,"eighty":39.214557,"high":47.14961,"avg":28.462617,"sd":11.206555,"marketCap":4934037104},"quantilePoints":[{"date":"2026-07-03","current":17.947787,"twenty":17.790004,"median":17.849172,"eighty":17.908341,"marketCap":1964363522},{"date":"2026-07-10","current":12.666339,"twenty":12.041485,"median":13.811255,"eighty":17.137167,"marketCap":1384614162},{"date":"2026-07-17","current":19.086739,"twenty":12.428421,"median":14.247428,"eighty":17.908341,"marketCap":2093881996},{"date":"2026-07-24","current":36.000914,"twenty":12.671426,"median":17.750558,"eighty":25.299158,"marketCap":3950313456},{"date":"2026-07-31","current":42.889169,"twenty":12.691776,"median":19.086739,"eighty":36.000914,"marketCap":4715089207},{"date":"2026-08-07","current":26.960254,"twenty":13.811255,"median":25.241686,"eighty":35.873669,"marketCap":2969673581},{"date":"2026-08-14","current":39.144998,"twenty":14.683601,"median":26.960254,"eighty":38.662714,"marketCap":4317282466},{"date":"2026-08-21","current":44.63849,"twenty":14.976114,"median":28.865244,"eighty":39.214557,"marketCap":4934037104}],"updateTime":1787472022622},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06915\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1173344381","title":"CMSC Initiates Coverage on JIANGXI BIO with \"Accumulate\" Rating and HK$23.6 Target Price","url":"https://stock-news.laohu8.com/highlight/detail?id=1173344381","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173344381?lang=en_us&edition=fundamental","pubTime":"2026-08-20 10:27","pubTimestamp":1787192844,"startTime":"0","endTime":"0","summary":"CMSC has published a research report initiating coverage on JIANGXI BIO (06915) with an \"Accumulate\" rating and a target price of HK$23.6. The brokerage highlights that the company is accelerating...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1564","EWH","06915","BK1161","BK1147","06099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660404234","title":"China Merchants Securities Starts Jiangxi Institute of Biological Products at Buy with HK$23.60 Price Target","url":"https://stock-news.laohu8.com/highlight/detail?id=2660404234","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660404234?lang=en_us&edition=fundamental","pubTime":"2026-08-19 19:44","pubTimestamp":1787139842,"startTime":"0","endTime":"0","summary":"China Merchants Securities Starts Jiangxi Institute of Biological Products at Buy with HK$23.60 Price Target","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK1161","06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483106","title":"Jiangxi Institute of Biological Products Schedules Board Meeting to Release Interim Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483106","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483106?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:34","pubTimestamp":1786955662,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products schedules board meeting to release interim resultsJiangxi Institute of Biological Products will hold a board meeting on Aug. 31, 2026.Directors are set to revi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nNDL5G8nXS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1173422210","title":"Jiangxi Bio Executive Director Buys 1.128 Million Shares Over Three Days, Stake Rises to 0.37%","url":"https://stock-news.laohu8.com/highlight/detail?id=1173422210","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1173422210?lang=en_us&edition=fundamental","pubTime":"2026-07-30 20:18","pubTimestamp":1785413906,"startTime":"0","endTime":"0","summary":"JIANGXI BIO (06915) shares experienced insider buying as executive director Jing Ruihua increased his holdings over three consecutive trading sessions.According to filings with the Hong Kong Stock...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125647376","title":"Jiangxi Bio's Stock Surges Nearly 320% in Two Weeks, Reversing Its IPO Slump","url":"https://stock-news.laohu8.com/highlight/detail?id=1125647376","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125647376?lang=en_us&edition=fundamental","pubTime":"2026-07-29 09:36","pubTimestamp":1785288989,"startTime":"0","endTime":"0","summary":"Jiangxi Bio (06915) experienced a dramatic \"V-shaped\" reversal within its first month of trading on the Hong Kong Stock Exchange, swinging from an IPO-day loss and a sharp 60% drop below its offer...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IPOS","06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060428","title":"Jiangxi Institute of Biological Products - Commences Veterinary Tetanus Antitoxin Production on July 20, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060428","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060428?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:05","pubTimestamp":1785110701,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nFWN43S00Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654060446","title":"Jiangxi Bio Products Unit Chifeng Bo-en Starts Veterinary Tetanus Antitoxin Production Line","url":"https://stock-news.laohu8.com/highlight/detail?id=2654060446","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654060446?lang=en_us&edition=fundamental","pubTime":"2026-07-27 08:04","pubTimestamp":1785110696,"startTime":"0","endTime":"0","summary":"Jiangxi Bio Products unit Chifeng Bo-en starts veterinary tetanus antitoxin production lineChifeng Bo-en, a wholly owned unit of Jiangxi Institute of Biological Products, started production on its vet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDLb17D7V:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125783124","title":"Jiangxi Bio (06915) Concludes Price Stabilization Period, Over-Allotment Option Lapses","url":"https://stock-news.laohu8.com/highlight/detail?id=1125783124","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125783124?lang=en_us&edition=fundamental","pubTime":"2026-07-26 19:04","pubTimestamp":1785063851,"startTime":"0","endTime":"0","summary":"Jiangxi Bio (06915) has announced that the price stabilization period related to its global offering concluded on July 25, 2026, which is the 30th day after the deadline for submitting Hong Kong...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1137493915","title":"Jiangxi Bio Ends Stabilization; Over-Allotment Option Lapses with No Additional H-Share Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=1137493915","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1137493915?lang=en_us&edition=fundamental","pubTime":"2026-07-26 18:23","pubTimestamp":1785061404,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) announced that the 30-day post-listing stabilization period for its Global Offering concluded on 25 July 2026 under section 9(2) of Hong...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654806548","title":"Jiangxi Institute of Biological Products Says Stabilizing Manager Buys 5,435,000 H Shares at Hk$7.4-hk$10.46","url":"https://stock-news.laohu8.com/highlight/detail?id=2654806548","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654806548?lang=en_us&edition=fundamental","pubTime":"2026-07-26 18:21","pubTimestamp":1785061315,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products says stabilizing manager buys 5,435,000 H shares at HK$7.4-HK$10.46Stabilization period for the global offering ended on July 25, 2026.Stabilizing manager over-allocated 5,435,000 H shares in the international offering, about 15% of initial offer shares.Successive on-market purchases totaled 5,435,000 H shares at HK$ 7.4 to HK$ 10.46 to cover the over-allocation.Last stabilizing purchase was on June 30, 2026 at HK$ 9.78 per H share.Over-allotment option was not exercised and lapsed on July 25, 2026; no H shares will be issued under it.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jiangxi Institute of Biological Products Inc. published the original content used to generate this news brief via II","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260726:nNDL9tjJ6S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158447014","title":"HK Movers | Jiangxi Bio Rallied Nearly 40% Intraday","url":"https://stock-news.laohu8.com/highlight/detail?id=1158447014","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158447014?lang=en_us&edition=fundamental","pubTime":"2026-07-24 15:40","pubTimestamp":1784878844,"startTime":"0","endTime":"0","summary":"$JIANGXI BIO(06915)$ Rallied Nearly 40% Intraday, Paring Gains to about 27%.","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135234202","title":"JIANGXI BIO Surges Over 17% to Record High After Subsidiary Obtains Veterinary Tetanus Antitoxin Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1135234202","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1135234202?lang=en_us&edition=fundamental","pubTime":"2026-07-24 14:58","pubTimestamp":1784876310,"startTime":"0","endTime":"0","summary":"JIANGXI BIO (06915) saw its share price climb more than 17% during the trading session, reaching an intraday high of HK$12.11, a new all-time high since its listing. At the time of writing, the stock...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915","BK4588","VXUS","BK4585","KCAI","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649309983","title":"Jiangxi Institute of Biological Products Says Unit Obtains Approval Certificate for Veterinary Tetanus Antitoxin","url":"https://stock-news.laohu8.com/highlight/detail?id=2649309983","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649309983?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:44","pubTimestamp":1783413850,"startTime":"0","endTime":"0","summary":"July 3 (Reuters) - Jiangxi Institute of Biological Products Inc <6915.HK>::*SUBSIDIARY OBTAINS APPROVAL CERTIFICATE FOR VETERINARY TETANUS ANTITOXIN*Further company coverage: 6915.HK* ((Reuters.Briefs","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nRSDbKvMQ8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1198210747","title":"Jiangxi Bio: First Post-Listing Monthly Return Shows Stable Share Capital and Full Public Float Compliance","url":"https://stock-news.laohu8.com/highlight/detail?id=1198210747","media":"Bulletin Express","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1198210747?lang=en_us&edition=fundamental","pubTime":"2026-07-07 16:42","pubTimestamp":1783413761,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) released its inaugural Monthly Return for the period ended 30 June 2026, confirming that no changes occurred in either its authorised or...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649649684","title":"Jiangxi Institute of Biological Products Sets Final Offer Price Under Global Offering at Hk$11.2 Per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2649649684","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649649684?lang=en_us&edition=fundamental","pubTime":"2026-07-06 15:12","pubTimestamp":1783321928,"startTime":"0","endTime":"0","summary":"June 29 (Reuters) - Jiangxi Institute of Biological Products Inc <6915.HK>::*FINAL OFFER PRICE UNDER GLOBAL OFFERING SET AT HK$11.2 PER H SHARE*Further company coverage: 6915.HK* ((Reuters.Briefs@thom","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nRSD74KT8f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648966325","title":"Jiangxi Institute of Biological Products Sets Final Offer Price Under Global Offering at Hk$11.2 Per H Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2648966325","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648966325?lang=en_us&edition=fundamental","pubTime":"2026-07-03 19:10","pubTimestamp":1783077016,"startTime":"0","endTime":"0","summary":"June 29 (Reuters) - Jiangxi Institute of Biological Products Inc <6915.HK>::*FINAL OFFER PRICE UNDER GLOBAL OFFERING SET AT HK$11.2 PER H SHARE*Further company coverage: 6915.HK* ((Reuters.Briefs@thom","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260703:nRSD74KT8f:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648653305","title":"Jiangxi Bio Unit Wins China Nod for Veterinary Tetanus Antitoxin","url":"https://stock-news.laohu8.com/highlight/detail?id=2648653305","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648653305?lang=en_us&edition=fundamental","pubTime":"2026-07-03 12:51","pubTimestamp":1783054273,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products'  wholly owned subsidiary, Chifeng Bo-en Pharmaceutical, received an approval certificate from Chinese regulators for its veterinary tetanus antitoxin, according to a Friday Hong Kong bourse filing.The product is used to prevent and treat tetanus infections in animals by neutralizing tetanus toxin and providing passive immune protection to animals at risk of infection.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1185086992","title":"Movement Alert｜Jiangxi Biologics Rises 9.52% in Regular Trading, Subsidiary Obtains Veterinary Tetanus Antitoxin Product Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1185086992","media":"Market Focus","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1185086992?lang=en_us&edition=fundamental","pubTime":"2026-07-03 09:58","pubTimestamp":1783043903,"startTime":"0","endTime":"0","summary":"On July 3, Jiangxi Biologics rose 9.52% in regular trading, trading at HKD 6.82/share, with turnover of HKD 1.8971 million.On the news front, the company announced that its wholly-owned subsidiary...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1131987482","title":"JIANGXI BIO's Wholly-Owned Subsidiary Secures Regulatory Approval for Veterinary Tetanus Antitoxin","url":"https://stock-news.laohu8.com/highlight/detail?id=1131987482","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1131987482?lang=en_us&edition=fundamental","pubTime":"2026-07-03 06:57","pubTimestamp":1783033063,"startTime":"0","endTime":"0","summary":"The company JIANGXI BIO (ASX: 06915) has announced that its wholly-owned subsidiary, Chifeng Boen Pharmaceutical Co., Ltd., has recently obtained the official approval document for its veterinary...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106495850","title":"Jiangxi Bio Gains Regulatory Green Light for Veterinary Tetanus Antitoxin, Expanding Animal Health Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=1106495850","media":"Bulletin Express","labels":["policyRegulatory","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106495850?lang=en_us&edition=fundamental","pubTime":"2026-07-03 06:43","pubTimestamp":1783032232,"startTime":"0","endTime":"0","summary":"Jiangxi Institute of Biological Products Inc. (Jiangxi Bio) announced that its wholly owned subsidiary, Chifeng Bo-en Pharmaceutical Co., Ltd., has secured the Approval Certificate of Veterinary Drug...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06915"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":39,"code":"91000000","status":"200"}]}}